Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells. (Q44564135)
scientific article published in August 2003
Language:
(P31) (Q13442814)
(P304) 5126-5135
(P407) (Q1860)
(P433) 16
(P478) 63
(P577) Friday, August 1, 2003
(P921) (Q29496)
(Q177094)
(P1433) (Q326097)
(P1476) "Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells" (language: en)
(P2093) Ramadevi Nimmanapalli
Lianne Fuino
Purva Bali
Maura Gasparetto
Michele Glozak
Jianguo Tao
Lynn Moscinski
Clayton Smith
Jie Wu
Richard Jove
Peter Atadja
Kapil Bhalla
other details
description scientific article published in August 2003

External Links